Doctor profile · Federal record

Dr. Katisha Vance, M.D.

Hematology & Oncology Physician (CMS: Medical Oncology) · Birmingham, AL

  • NPI 1467526442
  • Accepts Medicare
  • MIPS 78.7 / 100 · 2023
  • 26 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
833 Princeton Ave Sw Ste 105A, Pob III
Birmingham, AL 352111323
(205) 786-6983
fax (205) 786-6987
Mailing address
500 Office Park Dr, Suite 400
Birmingham, AL 352232437

Credentials & registration

NPPES · NUCC
NPI registered
November 2006 — 20 yrs on file
Profile last updated
June 4, 2015
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Alabama #24465
Medicaid
AL #051556668

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1467526442. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
62,712
Distinct HCPCS
10
Medicare allowed
$329,074
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 47,430 42 $0
J0897 Injection, denosumab, 1 mg 8,220 19 $21
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,784 25 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 708 177 $7
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 590 64 $26
36415 Insertion of needle into vein for collection of blood sample 510 179 $8
J2469 Injection, palonosetron hcl, 25 mcg 490 12 $1
96413 Administration of chemotherapy into vein, 1 hour or less 238 31 $115
96372 Injection of drug or substance under skin or into muscle 219 46 $12
96375 Injection of additional new drug or substance into vein 206 58 $14

In context: peer comparison

Among 34 peers in this city , average services per provider: 1,964. This provider delivers 32× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,057
Transactions
51
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Daiichi Sankyo Inc. 11 $235.12
AstraZeneca Pharmaceuticals LP 10 $194.01
ABBVIE INC. 7 $137.92
Stemline Therapeutics Inc. 3 $73.60
E.R. Squibb & Sons, L.L.C. 4 $63.09
PFIZER INC. 3 $62.86
Novartis Pharmaceuticals Corporation 3 $55.66
Gilead Sciences, Inc. 2 $39.67
Bayer Healthcare Pharmaceuticals Inc. 2 $36.50
Merck Sharp & Dohme LLC 1 $23.54
Eisai Inc. 1 $23.14
SOBI, INC 1 $22.08
SpringWorks Therapeutics, Inc. 1 $20.02
Aveo Pharmaceuticals, Inc. 1 $19.69
MorphoSys, US Inc. 1 $18.81

By nature of payment

Food and Beverage
$1,057

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,652
Patients
538
Total drug cost
$46,526
Drug Type Claims Patients Total cost
Anastrozole Generic 230 71 $8,326
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 182 42 $6,155
Ondansetron Hcl Generic 156 52 $1,001
Prochlorperazine Maleate Generic 134 90 $3,252
Dexamethasone Generic 132 41 $850
Gabapentin Generic 116 28 $2,198
Morphine Sulfate Er (Morphine Sulfate) Brand 101 15 $3,466
Promethazine Hcl Generic 90 56 $936
Potassium Chloride Generic 89 32 $1,539
Prednisone Generic 84 14 $521

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Katisha Vance's medical specialty?
Dr. Katisha Vance practices Hematology & Oncology Physician in Birmingham, AL.
Where does Dr. Katisha Vance practice?
Dr. Katisha Vance practices at 833 Princeton Ave Sw Ste 105A, Birmingham, AL 352111323. Office phone: 2057866983.
What is Dr. Katisha Vance's NPI?
Dr. Katisha Vance's National Provider Identifier (NPI) is 1467526442, issued by NPPES.
Does Dr. Katisha Vance accept Medicare assignment?
Yes. Dr. Katisha Vance accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Katisha Vance commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.